Please Login to read the full article.
Clinica
Quarterly results round-up: “no better, no worse” for Bard, Roche suffers from exchange rates again
01 February 2012
Madeleine Armstrong
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Bard gains "promising" balloon tech with Lutonix buy
- Quarterly results round-up: LabCorp, Bard hit by legal costs; Edwards, Intuitive grow top and bottom lines
- Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
- Quarterly results round-up: Covidien shows strong start, Recon still weak but other units give boost to Zimmer and Stryker
Other Informa News
EVENTS
